Notch activation drives resistance to Kras(G12C) inhibition in lung adenocarcinoma

被引：0
|
作者：
Hwang, Elizabeth E. [1 ]
Lee, Alex [1 ]
Leung, Stanley [1 ]
Breese, Marcus [1 ]
Sweet-Cordero, Alejandro [1 ]
机构：
[1] Univ Calif San Francisco, San Francisco, CA USA
来源：
CANCER RESEARCH | 2022年 / 82卷 / 12期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1107
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Oncogenic KRAS G12C: Kinetic and redox characterization of covalent inhibition
    Huynh, Minh, V
    Parsonage, Derek
    Forshaw, Tom E.
    Chirasani, Venkat R.
    Hobbs, G. Aaron
    Wu, Hanzhi
    Lee, Jingyun
    Furdui, Cristina M.
    Poole, Leslie B.
    Campbell, Sharon L.
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2022, 298 (08)
  • [32] SRC kinase drives multidrug resistance induced by KRAS-G12C inhibition
    Song, Xinxin
    Zhou, Zhuan
    Elmezayen, Ammar
    Wu, Runliu
    Yu, Chunhua
    Gao, Boning
    Minna, John D.
    Westover, Kenneth D.
    Zeh, Herbert J.
    Kroemer, Guido
    Heasley, Lynn E.
    Kang, Rui
    Tang, Daolin
    SCIENCE ADVANCES, 2024, 10 (50):
  • [33] KRAS G12C mutated lung adenocarcinomas: a morphological and molecular cartography
    Pirlog, R.
    Piton, N.
    Marguet, F.
    Lamy, A.
    Sabourin, J.
    VIRCHOWS ARCHIV, 2021, 479 : S162 - S162
  • [34] Combination of tipifarnib with KRAS G12C inhibitors to prevent adaptive resistance
    Patel, Hetika Vora
    Smith, Alison
    Chan, Stacia
    Kessler, Linda
    Burrows, Francis
    Malik, Shivani
    CANCER RESEARCH, 2023, 83 (07)
  • [35] Resistance looms for KRAS G12C inhibitors and rational tackling strategies
    Zhang, Junmin
    Zhang, Juanhong
    Liu, Qing
    Fan, Xing-Xing
    Leung, Elaine Lai-Han
    Yao, Xiao-Jun
    Liu, Liang
    PHARMACOLOGY & THERAPEUTICS, 2022, 229
  • [36] AXL signal mediates adaptive resistance to KRAS G12C inhibitors in KRAS G12C-mutant tumor cells
    Morimoto, Kenji
    Yamada, Tadaaki
    Hirai, Soichi
    Katayama, Yuki
    Fukui, Sarina
    Sawada, Ryo
    Tachibana, Yusuke
    Matsui, Yohei
    Nakamura, Ryota
    Ishida, Masaki
    Kawachi, Hayato
    Kunimasa, Kei
    Sasaki, Takaaki
    Nishida, Makoto
    Furuya, Naoki
    Watanabe, Satoshi
    Shiotsu, Shinsuke
    Nishioka, Naoya
    Horinaka, Mano
    Sakai, Toshiyuki
    Uehara, Hisanori
    Yano, Seiji
    Son, Bo-Kyung
    Tokuda, Shinsaku
    Takayama, Koichi
    CANCER LETTERS, 2024, 587
  • [37] Concomitant KRAS mutations attenuate sensitivity of non-small cell lung cancer cells to KRAS G12C inhibition
    Tereza Vaclova
    Atanu Chakraborty
    James Sherwood
    Sarah Ross
    Danielle Carroll
    J. Carl Barrett
    Julian Downward
    Elza C. de Bruin
    Scientific Reports, 12
  • [38] Association Between Histological Subtypes of Lung Adenocarcinoma and KRAS Mutations, with an Emphasis on G12C Mutations: A Pilot Study
    Keogh, A.
    O'Brien, C.
    Ward, R.
    Murchan, P.
    Baird, A. M.
    Gray, S. G.
    Finn, S. P.
    JOURNAL OF PATHOLOGY, 2022, 256 : S4 - S4
  • [39] KRAS G12C mutation is not undruggable anymore
    Rodrigues, Manuel
    BULLETIN DU CANCER, 2020, 107 (02) : 145 - 145
  • [40] Concomitant KRAS mutations attenuate sensitivity of non-small cell lung cancer cells to KRAS G12C inhibition
    Vaclova, Tereza
    Chakraborty, Atanu
    Sherwood, James
    Ross, Sarah
    Carroll, Danielle
    Barrett, J. Carl
    Downward, Julian
    de Bruin, Elza C.
    SCIENTIFIC REPORTS, 2022, 12 (01)
12345